Several institutional investors recently bought and sold shares of Cronos Group. ClariVest Asset Management LLC increased its stake in the company by 2.8% in the second quarter. Toronto Dominion Bank also raised its position in Cronos Group by 204.8% in the 1st quarter. National Bank of Canada FI saw a 1,094.4% boost in its shares during the 2nd quarter. Cedar Wealth Management LLC and SeaCrest Wealth Management LLC also saw increases in their holdings. 8.71% of the stock is owned by hedge funds and other institutional investors.
Cronos Group Price Performance
Cronos Group stock opened at $2.13 on Wednesday, with a 52-week range of $1.70 to $3.14. The stock has a market capitalization of $814.26 million, a PE ratio of -14.20, and a beta of 0.97.
Cronos Group (NASDAQ:CRON – Get Free Report) reported ($0.02) earnings per share and $27.76 million in revenue for the quarter ended August 8th. Analysts expect Cronos Group Inc. to post -0.05 EPS for the current fiscal year.
About Cronos Group
(Free Report) Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production, and marketing of cannabis products in Canada, Israel, and Germany.
Read More
- Five stocks we like better than Cronos Group
- What is the S&P/TSX Index?
- Why Lennar Stock Could Be the Best Play in the Housing Market
- Why is the Ex-Dividend Date Significant to Investors?
- 2 Energy Stocks Fueling the AI Datacenter Boom
- How to Calculate Return on Investment (ROI)
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
